WO2004011055A3 - Implantable or insertable medical devices for controlled drug delivery - Google Patents

Implantable or insertable medical devices for controlled drug delivery Download PDF

Info

Publication number
WO2004011055A3
WO2004011055A3 PCT/US2003/024131 US0324131W WO2004011055A3 WO 2004011055 A3 WO2004011055 A3 WO 2004011055A3 US 0324131 W US0324131 W US 0324131W WO 2004011055 A3 WO2004011055 A3 WO 2004011055A3
Authority
WO
WIPO (PCT)
Prior art keywords
medical devices
implantable
insertable medical
agent
implantation
Prior art date
Application number
PCT/US2003/024131
Other languages
French (fr)
Other versions
WO2004011055A2 (en
Inventor
Jianmin Li
Danielle Conley
Weenna Bucay-Couto
Cang Duy Dao
Hamid Davoudi
Raymond Lareau
Kathleen M Miller
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/209,476 external-priority patent/US8685427B2/en
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Priority to EP03748999A priority Critical patent/EP1526880B1/en
Priority to CA002506963A priority patent/CA2506963A1/en
Priority to AU2003268048A priority patent/AU2003268048A1/en
Priority to JP2004524281A priority patent/JP4918222B2/en
Publication of WO2004011055A2 publication Critical patent/WO2004011055A2/en
Publication of WO2004011055A3 publication Critical patent/WO2004011055A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A61L2/232—Solid substances, e.g. granules, powders, blocks, tablets layered or coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Abstract

Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.
PCT/US2003/024131 2002-07-31 2003-07-31 Implantable or insertable medical devices for controlled drug delivery WO2004011055A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03748999A EP1526880B1 (en) 2002-07-31 2003-07-31 Implantable or insertable medical devices for controlled drug delivery
CA002506963A CA2506963A1 (en) 2002-07-31 2003-07-31 Implantable or insertable medical devices for controlled drug delivery
AU2003268048A AU2003268048A1 (en) 2002-07-31 2003-07-31 Implantable or insertable medical devices for controlled drug delivery
JP2004524281A JP4918222B2 (en) 2002-07-31 2003-07-31 Implantable or insertable medical device for controlled release of drugs

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/209,476 US8685427B2 (en) 2002-07-31 2002-07-31 Controlled drug delivery
US10/209,476 2002-07-31
US10/377,131 2003-02-28
US10/377,131 US8133501B2 (en) 2002-02-08 2003-02-28 Implantable or insertable medical devices for controlled drug delivery

Publications (2)

Publication Number Publication Date
WO2004011055A2 WO2004011055A2 (en) 2004-02-05
WO2004011055A3 true WO2004011055A3 (en) 2004-07-22

Family

ID=31190695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024131 WO2004011055A2 (en) 2002-07-31 2003-07-31 Implantable or insertable medical devices for controlled drug delivery

Country Status (6)

Country Link
US (2) US8133501B2 (en)
EP (1) EP1526880B1 (en)
JP (1) JP4918222B2 (en)
AU (1) AU2003268048A1 (en)
CA (1) CA2506963A1 (en)
WO (1) WO2004011055A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852163B2 (en) 2002-04-08 2014-10-07 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
US9192715B2 (en) 2002-04-08 2015-11-24 Medtronic Ardian Luxembourg S.A.R.L. Methods for renal nerve blocking
US9265558B2 (en) 2002-04-08 2016-02-23 Medtronic Ardian Luxembourg S.A.R.L. Methods for bilateral renal neuromodulation

Families Citing this family (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US20060030826A1 (en) * 1996-06-04 2006-02-09 Vance Products Incorporated,d/b/a Cook Urological Incorporated Implantable medical device with anti-neoplastic drug
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
US20060025726A1 (en) * 1996-06-04 2006-02-02 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with pharmacologically active layer
ATE350077T1 (en) 2000-04-11 2007-01-15 Polyzenix Gmbh USE OF FILMS MADE OF POLY-TRI-FLUORINE-ETHOXYPOLYPHOSPHAZENES FOR COVERING MEDICAL DEVICES
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20040253467A1 (en) 2001-08-17 2004-12-16 Schuessler Andreas Device based on nitinol with a polyphosphazene coating
US7993390B2 (en) * 2002-02-08 2011-08-09 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8920826B2 (en) 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US9114199B2 (en) * 2003-07-31 2015-08-25 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
US7914805B2 (en) * 2003-07-31 2011-03-29 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing radiation-treated polymer for improved delivery of therapeutic agent
TWI434676B (en) * 2004-03-19 2014-04-21 Merck Sharp & Dohme X-ray visible drug delivery device
US20060020328A1 (en) * 2004-07-23 2006-01-26 Tan Sharon M L Composite vascular graft having bioactive agent
CN101035593B (en) * 2004-07-28 2011-05-25 阿迪安公司 Methods and devices for renal nerve blocking
PT1781264E (en) 2004-08-04 2013-10-16 Evonik Corp Methods for manufacturing delivery devices and devices thereof
US8313524B2 (en) 2004-08-31 2012-11-20 C. R. Bard, Inc. Self-sealing PTFE graft with kink resistance
DE112005002876A5 (en) * 2004-09-17 2007-08-30 Optiray Medizintechnik Gmbh support prosthesis
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
WO2006063199A2 (en) 2004-12-09 2006-06-15 The Foundry, Inc. Aortic valve repair
JP2009501027A (en) 2005-06-17 2009-01-15 シー・アール・バード・インコーポレイテツド Vascular graft with kinking resistance after tightening
US8367096B2 (en) * 2005-07-19 2013-02-05 Boston Scientific Scimed, Inc. Polymers having covalently bound therapeutic agents
US20070078413A1 (en) * 2005-08-25 2007-04-05 Stenzel Eric B Medical device having a lubricant
US20070173787A1 (en) * 2005-11-01 2007-07-26 Huang Mark C T Thin-film nitinol based drug eluting stent
BRPI0618499A2 (en) * 2005-11-09 2011-09-06 Novartis Ag process for producing pharmaceutical compositions with a transient plasticizer
US8636794B2 (en) 2005-11-09 2014-01-28 C. R. Bard, Inc. Grafts and stent grafts having a radiopaque marker
US8440214B2 (en) 2006-01-31 2013-05-14 Boston Scientific Scimed, Inc. Medical devices for therapeutic agent delivery with polymeric regions that contain copolymers having both soft segments and uniform length hard segments
US8591531B2 (en) 2006-02-08 2013-11-26 Tyrx, Inc. Mesh pouches for implantable medical devices
MX2008010126A (en) 2006-02-08 2010-02-22 Tyrx Pharma Inc Temporarily stiffened mesh prostheses.
WO2007100883A2 (en) * 2006-02-28 2007-09-07 Tyco Healthcare Group Lp Antimicrobial releasing polymers
JP2009528132A (en) * 2006-02-28 2009-08-06 タイコ ヘルスケア グループ リミテッド パートナーシップ Antibacterial medical device
US20070231363A1 (en) * 2006-03-29 2007-10-04 Yung-Ming Chen Coatings formed from stimulus-sensitive material
CA2652753C (en) * 2006-05-12 2015-12-08 Cordis Corporation Balloon expandable bioabsorbable drug eluting stent
CA2652871C (en) * 2006-05-12 2016-01-12 Cordis Corporation Balloon expandable bioabsorbable drug eluting flexible stent
US20090252789A1 (en) * 2006-05-19 2009-10-08 Gil Trophardy One step spray-drying process
US7951194B2 (en) * 2006-05-26 2011-05-31 Abbott Cardiovascular Sysetms Inc. Bioabsorbable stent with radiopaque coating
US8048168B2 (en) 2006-06-16 2011-11-01 Boston Scientific Scimed, Inc. Partially soluble implantable or insertable medical devices
US20070298069A1 (en) * 2006-06-26 2007-12-27 Boston Scientific Scimed, Inc. Medical devices for release of low solubility therapeutic agents
US9265865B2 (en) * 2006-06-30 2016-02-23 Boston Scientific Scimed, Inc. Stent having time-release indicator
US9585989B2 (en) * 2006-09-19 2017-03-07 Boston Scientific Scimed, Inc. Ureteral stent having variable hardness
US7713308B2 (en) * 2006-09-22 2010-05-11 Boston Scientific Scimed, Inc. Stent with soluble bladder retention member
US20080075628A1 (en) * 2006-09-27 2008-03-27 Medtronic, Inc. Sterilized minocycline and rifampin-containing medical device
US8298564B2 (en) * 2006-09-27 2012-10-30 Medtronic, Inc. Two part antimicrobial boot
JP2010505597A (en) 2006-10-10 2010-02-25 セロノバ バイオサイエンシーズ， インコーポレイテッド Bioprosthetic heart valve using polyphosphazene
US9198749B2 (en) 2006-10-12 2015-12-01 C. R. Bard, Inc. Vascular grafts with multiple channels and methods for making
US20080102098A1 (en) * 2006-10-30 2008-05-01 Vipul Bhupendra Dave Method for making a device having discrete regions
AU2006350695B2 (en) * 2006-11-06 2013-08-15 Cerebel-Invest Sa Resorbable intra-urethral prosthesis
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
US20080132991A1 (en) * 2006-11-30 2008-06-05 Leonard Pinchuk Method for Ionically Cross-Linking Gellan Gum for Thin Film Applications and Medical Devices Produced Therefrom
US20080167710A1 (en) * 2007-01-05 2008-07-10 Vipul Bhupendra Dave Medical Device Having Regions With Various Agents Dispersed Therein and a Method for Making the Same
JP2010522023A (en) * 2007-03-20 2010-07-01 ボストン サイエンティフィック サイムド，インコーポレイテッド Urological medical device for releasing beneficial therapeutics to the prostate
US20080269874A1 (en) * 2007-04-30 2008-10-30 Yunbing Wang Implantable medical devices fabricated from polymers with radiopaque groups
CN101801521B (en) 2007-05-14 2015-06-17 纽约州立大学研究基金会 Induction of a physiological dispersion response in bacterial cells in a biofilm
US8202528B2 (en) * 2007-06-05 2012-06-19 Abbott Cardiovascular Systems Inc. Implantable medical devices with elastomeric block copolymer coatings
EP2018864A1 (en) * 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US8241657B2 (en) 2007-12-04 2012-08-14 Boston Scientific Scimed, Inc. Biodisintegrable medical devices
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
JP5502751B2 (en) 2007-12-20 2014-05-28 エボニック コーポレイション Process for preparing microparticles with low residual solvent concentration
US20090171465A1 (en) * 2007-12-28 2009-07-02 Boston Scientific Scimed, Inc. Polymeric Regions For Implantable Or Insertable Medical Devices
EP2271391B1 (en) 2008-03-27 2019-10-30 Boston Scientific Scimed, Inc. Ureteral stents for release of urologically beneficial agents
US20090263443A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedics, Inc. Methods for treating post-operative effects such as spasticity and shivering with clondine
US20090264478A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Sulfasalazine formulations in a biodegradable polymer carrier
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8956641B2 (en) 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
US9132085B2 (en) 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US8846068B2 (en) 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
US9072727B2 (en) 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US8420114B2 (en) 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US8629172B2 (en) 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US8956636B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprosing ketorolac
US20100015049A1 (en) * 2008-07-16 2010-01-21 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
US8822546B2 (en) * 2008-12-01 2014-09-02 Medtronic, Inc. Flowable pharmaceutical depot
US8980317B2 (en) * 2008-12-23 2015-03-17 Warsaw Orthopedic, Inc. Methods and compositions for treating infections comprising a local anesthetic
EP2373270B8 (en) 2009-01-07 2023-04-12 entrotech life sciences, inc. Chlorhexidine-containing antimicrobial laminates
WO2010096771A2 (en) 2009-02-20 2010-08-26 The General Hospital Corporation Dba High temperature melting
US20100234815A1 (en) * 2009-03-11 2010-09-16 Teleflex Medical Incorporated Stable melt processable chlorhexidine compositions
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US8617583B2 (en) 2009-07-17 2013-12-31 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US8231891B2 (en) 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
GB0921203D0 (en) * 2009-12-03 2010-01-20 Al Lamee Kadem G Drugs formulations for cardiovascular stents
US9486500B2 (en) 2010-01-28 2016-11-08 Warsaw Orthopedic, Inc. Osteoimplant and methods for making
US9050274B2 (en) * 2010-01-28 2015-06-09 Warsaw Orthopedic, Inc. Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
US9125902B2 (en) * 2010-01-28 2015-09-08 Warsaw Orthopedic, Inc. Methods for treating an intervertebral disc using local analgesics
WO2011122571A1 (en) * 2010-03-29 2011-10-06 株式会社ジェイ・エム・エス Contrast-medium-containing bioabsorbable stent and medical device including same
US9861590B2 (en) * 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
US8404268B2 (en) 2010-10-26 2013-03-26 Kyphon Sarl Locally targeted anti-fibrotic agents and methods of use
US8740982B2 (en) 2010-10-26 2014-06-03 Kyphon Sarl Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
US9414930B2 (en) * 2010-10-26 2016-08-16 Kyphon SÀRL Activatable devices containing a chemonucleolysis agent
US8623396B2 (en) 2010-12-03 2014-01-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
WO2012075451A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
US9060978B2 (en) 2011-01-24 2015-06-23 Warsaw Orthopedic, Inc. Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
CA2832311A1 (en) 2011-04-08 2012-11-29 Covidien Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US9511077B2 (en) 2011-04-25 2016-12-06 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for wound healing
US9592243B2 (en) 2011-04-25 2017-03-14 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for treatment of an injury
US9511018B2 (en) 2012-04-05 2016-12-06 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable matrix
CN102784015B (en) * 2012-08-30 2015-06-03 广州迈普再生医学科技有限公司 Artificial blood vessel loaded with pseudo-ginseng medicines, and preparation method and application for artificial blood vessel
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
WO2014120587A1 (en) 2013-01-30 2014-08-07 Boston Scientific Scimed, Inc. Ureteral stent with drug-releasing structure
US9228996B2 (en) 2013-05-31 2016-01-05 Empire Technology Development Llc Method and device for detecting device colonization
US9535043B2 (en) * 2013-05-31 2017-01-03 Empire Technology Development Llc Color change indicator of biofilm formation
JP2017500171A (en) * 2013-11-05 2017-01-05 タリス バイオメディカル エルエルシー Osmotic drug delivery device, kit and method
EP3071250B1 (en) 2013-11-20 2019-06-05 DSM IP Assets B.V. Reducing the deterioration of wetted hydrophilic coatings subjected to sterilization by radiation
WO2015161302A1 (en) 2014-04-18 2015-10-22 Entrotech Life Sciences, Inc. Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
DK3277363T3 (en) 2015-03-30 2019-09-30 Taris Biomedical Llc Devices for local administration of drug to the upper urinary tract
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11541205B2 (en) * 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
MA45266A (en) 2015-07-20 2019-04-17 Strataca Systems Ltd CATHETER DEVICE AND METHOD FOR INDUCING NEGATIVE PRESSURE IN THE BLADDER OF A PATIENT
EP3367966A4 (en) 2015-10-30 2019-07-10 New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery Suture sleeve patch and methods of delivery within an existing arthroscopic workflow
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
US9949821B2 (en) * 2015-12-22 2018-04-24 Biosense Webster (Israel) Ltd. Colored silicone for implant safety
US10702260B2 (en) 2016-02-01 2020-07-07 Medos International Sàrl Soft tissue fixation repair methods using tissue augmentation scaffolds
US11484401B2 (en) 2016-02-01 2022-11-01 Medos International Sarl Tissue augmentation scaffolds for use in soft tissue fixation repair
USD802756S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
EP3551140A4 (en) 2016-12-09 2020-07-08 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
US11883565B2 (en) * 2017-03-17 2024-01-30 Gyrus Acmi, Inc. Ureteral stent
GB201708224D0 (en) * 2017-05-23 2017-07-05 Juniper Pharmaceuticals Uk Ltd Device
US11534283B2 (en) * 2017-09-06 2022-12-27 Children's National Medical Center Porous implantable devices
US11116561B2 (en) 2018-01-24 2021-09-14 Medtronic Ardian Luxembourg S.A.R.L. Devices, agents, and associated methods for selective modulation of renal nerves
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020198246A1 (en) * 2019-03-26 2020-10-01 The General Hospital Corporation Anti-microbial methods and materials
EP4061292A4 (en) 2019-11-19 2023-12-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347660A1 (en) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln Thermoplastics containing antiphlogistics
US5279594A (en) * 1990-05-23 1994-01-18 Jackson Richard R Intubation devices with local anesthetic effect for medical use
US5512055A (en) * 1991-02-27 1996-04-30 Leonard Bloom Anti-infective and anti-inflammatory releasing systems for medical devices
EP0970711A2 (en) * 1998-06-30 2000-01-12 Ethicon, Inc. Process for coating stents
WO2001003607A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Aneurysm closure device assembly

Family Cites Families (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3845480A (en) 1973-02-20 1974-10-29 Air Technologies Inc Particulate detector system
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4036227A (en) 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4054139A (en) 1975-11-20 1977-10-18 Crossley Kent B Oligodynamic catheter
US4186745A (en) 1976-07-30 1980-02-05 Kauzlarich James J Porous catheters
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4391797A (en) 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4240163A (en) 1979-01-31 1980-12-23 Galin Miles A Medicament coated intraocular lens
US4309996A (en) 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4603152A (en) 1982-11-05 1986-07-29 Baxter Travenol Laboratories, Inc. Antimicrobial compositions
US4472327A (en) 1983-01-31 1984-09-18 Neefe Charles W Method of making hydrogel cosmetic contact lenses
US4589880A (en) 1983-07-14 1986-05-20 Southern Research Institute Disposable spermicide-releasing diaphragm
GB2152382B (en) 1984-01-03 1988-04-20 Bristol Myers Co Surgical appliance e.g. ureteral stent
GB8403138D0 (en) 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4723950A (en) 1984-12-12 1988-02-09 C. R. Bard, Inc. Urine drainage bag outlet with barrier against microbial infection
US4731080A (en) 1985-01-18 1988-03-15 Galin Miles A Coated intraocular lens
DE204456T1 (en) 1985-05-17 1987-09-03 Nippon Paint Co., Ltd., Osaka, Jp MIXTURE BASED ON HYDROLIZABLE RESIN AND ANTI-GROWING PAINT COMPOSITION CONTAINING IT.
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4816264A (en) 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US5114719A (en) 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5527337A (en) 1987-06-25 1996-06-18 Duke University Bioabsorbable stent and method of making the same
JPS6415056A (en) 1987-07-09 1989-01-19 Hanarou Maeda Body indwelling tube
US5130159A (en) 1987-07-17 1992-07-14 Shlenker Robin R T Membranes fashioned from latex and other materials and methods of producing the same
US5679399A (en) 1987-07-17 1997-10-21 Bio Barrier, Inc. Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
US4853978A (en) 1987-07-24 1989-08-08 Surgikos, Inc. Antimicrobial medical glove
US5171318A (en) 1987-11-09 1992-12-15 Chiron Ophthalmics, Inc. Treated corneal prosthetic device
US4978391A (en) 1987-11-13 1990-12-18 Dentsply Management Corp. Intraoral medicament delivery and procedure
EP0318258B1 (en) 1987-11-25 1993-04-07 Unitika Ltd. Antimicrobial latex composition
US5019096A (en) 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5178870A (en) 1988-04-26 1993-01-12 Explore Antimicrobial composition with long-term activity
GB8820945D0 (en) 1988-09-07 1988-10-05 Smith & Nephew Medical articles
US4933178A (en) 1988-10-07 1990-06-12 Biointerface Technologies, Inc. Metal-based antimicrobial coating
US4946899A (en) 1988-12-16 1990-08-07 The University Of Akron Thermoplastic elastomers of isobutylene and process of preparation
US5091205A (en) 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
US5165952A (en) 1989-01-18 1992-11-24 Becton, Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US4925668A (en) 1989-01-18 1990-05-15 Becton, Dickinson And Company Anti-infective and lubricious medical articles and method for their preparation
JPH02299663A (en) 1989-05-15 1990-12-11 Unitika Ltd Anti-infectious catheter
US5272012A (en) 1989-06-23 1993-12-21 C. R. Bard, Inc. Medical apparatus having protective, lubricious coating
US5135516A (en) 1989-12-15 1992-08-04 Boston Scientific Corporation Lubricious antithrombogenic catheters, guidewires and coatings
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5261896A (en) 1990-01-10 1993-11-16 Rochester Medical Corporation Sustained release bactericidal cannula
US5098379A (en) 1990-01-10 1992-03-24 Rochester Medical Corporation Catheter having lubricated outer sleeve and methods for making and using same
US5137671A (en) 1990-01-10 1992-08-11 Rochester Medical Corporation Methods of making balloon catheters
WO1991017724A1 (en) 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5417671A (en) 1990-05-23 1995-05-23 Jackson; Richard R. Medical devices having local anesthetic effect and methods of their manufacture
AU8050791A (en) 1990-06-20 1992-01-07 Advanced Polymer Systems Inc. Compositions and methods for the controlled release of soluble active substances
US5102401A (en) 1990-08-22 1992-04-07 Becton, Dickinson And Company Expandable catheter having hydrophobic surface
US6248129B1 (en) 1990-09-14 2001-06-19 Quanam Medical Corporation Expandable polymeric stent with memory and delivery apparatus and method
US5102402A (en) 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5344411A (en) 1991-02-27 1994-09-06 Leonard Bloom Method and device for inhibiting HIV, hepatitis B and other viruses and germs when using a catheter in a medical environment
US5662913A (en) 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
US5370681A (en) 1991-09-16 1994-12-06 Atrium Medical Corporation Polyumenal implantable organ
US5282784A (en) 1991-10-09 1994-02-01 Mentor Corporation Injection stent system
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
GB2261672A (en) 1991-11-18 1993-05-26 Michael Braden The use of biomaterials for tissue repair
WO1993010847A1 (en) 1991-12-06 1993-06-10 North Shore University Hospital Research Corporation Method of reducing medical device related infections
JPH06506019A (en) 1991-12-18 1994-07-07 シメッド　ライフ　システムズ　インコーポレイテッド Lubricious polymer network
US6004438A (en) 1991-12-31 1999-12-21 3M Innovative Properties Company Biofilm reduction sterilizer
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5509900A (en) 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5254089A (en) 1992-04-02 1993-10-19 Boston Scientific Corp. Medication dispensing balloon catheter
US5656296A (en) 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5629008A (en) 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5611354A (en) 1992-11-12 1997-03-18 Alleyne; Neville Cardiac protection device
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5328954A (en) 1993-04-16 1994-07-12 Icet, Inc. Encrusting and bacterial resistant coatings for medical applications
DE69434598T3 (en) 1993-07-29 2010-07-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Use of paclitaxel and its derivatives for the manufacture of a medicament for the treatment of restenosis
US5380299A (en) 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
DE69432867T2 (en) 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood PREPARATION WITH CONTROLLED RELEASE
US5409012A (en) 1993-12-30 1995-04-25 Boston Scientific Corporation Sample collection using catheter with expandable member
US5599298A (en) 1993-12-30 1997-02-04 Boston Scientific Corporation Bodily sample collection balloon catheter method
US5849327A (en) 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5562652A (en) 1994-10-07 1996-10-08 Davis; William M. Antiseptic medical apparatus
US5676972A (en) 1995-02-16 1997-10-14 The University Of Akron Time-release delivery matrix composition and corresponding controlled-release compositions
US5702754A (en) 1995-02-22 1997-12-30 Meadox Medicals, Inc. Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
US6179817B1 (en) 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
US5605696A (en) 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5643207A (en) 1995-04-28 1997-07-01 Medtronic, Inc. Implantable techniques for infusing a therapeutic agent with endogenous bodily fluid
US5772640A (en) 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
AUPN596595A0 (en) 1995-10-13 1995-11-09 Priscott, Paul Kenneth Improvements in polymeric materials for use in medical applications
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5756145A (en) 1995-11-08 1998-05-26 Baylor College Of Medicine Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor
US5647843A (en) 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
GB9613010D0 (en) 1996-06-21 1996-08-28 Boc Group Plc Medical article
US6060534A (en) 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US5741331A (en) 1996-07-29 1998-04-21 Corvita Corporation Biostable elastomeric polymers having quaternary carbons
GB9624269D0 (en) 1996-11-21 1997-01-08 Rusch Manufacturing Uk Limited Packaged medical device
DE69831938T2 (en) 1997-02-20 2006-07-06 Cook Inc., Bloomington COATED, IMPLANTABLE MEDICAL DEVICES
DE19882286T1 (en) 1997-04-03 2000-04-27 Point Biomedical Corp Intravesical drug delivery systems
US6221467B1 (en) 1997-06-03 2001-04-24 Scimed Life Systems, Inc. Coating gradient for lubricious coatings on balloon catheters
US6316522B1 (en) 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6096108A (en) 1997-10-22 2000-08-01 Donaldson Company, Inc. Air cleaner mounting arrangement and method
CA2579619C (en) 1997-11-07 2012-01-03 Rutgers, The State University Radio-opaque polymeric biomaterials
JP5095049B2 (en) 1998-03-06 2012-12-12 バイオスフィアー メディカル，インク． Implantable particles for the treatment of tissue bulking and gastroesophageal reflux disease, urinary incontinence, skin wrinkles
GB9805487D0 (en) 1998-03-17 1998-05-13 Ici Plc Plastic material
US6641831B1 (en) 1998-08-06 2003-11-04 Schierholz Joerg Medical products with sustained pharmacological activity and process for producing them
US6335029B1 (en) 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6596401B1 (en) 1998-11-10 2003-07-22 C. R. Bard Inc. Silane copolymer compositions containing active agents
WO2000033895A1 (en) 1998-12-07 2000-06-15 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
US6224579B1 (en) 1999-03-31 2001-05-01 The Trustees Of Columbia University In The City Of New York Triclosan and silver compound containing medical devices
US6368658B1 (en) 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
US6176849B1 (en) 1999-05-21 2001-01-23 Scimed Life Systems, Inc. Hydrophilic lubricity coating for medical devices comprising a hydrophobic top coat
US6746481B1 (en) * 1999-06-28 2004-06-08 Medtronic, Inc. Implatable device including a polyamino acid component
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
WO2001021229A1 (en) 1999-09-23 2001-03-29 Lee Clarence C Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent
JP2004516230A (en) * 2000-04-04 2004-06-03 ボストン サイエンティフィック リミテッド Medical devices suitable for gene therapy regimens
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
DE60137334D1 (en) 2000-06-09 2009-02-26 Baylor College Medicine Combination of Antimicrobial Agents and Bacterial Interference for Transferring Medical Devices
US6858634B2 (en) 2000-09-15 2005-02-22 Monsanto Technology Llc Controlled release formulations and methods for their production and use
AU2002239255B2 (en) 2000-11-28 2006-06-15 Boston Scientific Limited Method and apparatus for delivery of therapeutic from a delivery matrix
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
AU2002314706B2 (en) 2001-01-12 2007-02-08 Board Of Regents, The University Of Texas System Novel antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces
EP1247537A1 (en) 2001-04-04 2002-10-09 Isotis B.V. Coating for medical devices
US6796960B2 (en) 2001-05-04 2004-09-28 Wit Ip Corporation Low thermal resistance elastic sleeves for medical device balloons
US6524268B2 (en) 2001-06-12 2003-02-25 George M. Hayner Combination ureteral infusion catheter/drainage stent
US6921390B2 (en) 2001-07-23 2005-07-26 Boston Scientific Scimed, Inc. Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
US7547321B2 (en) 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US7195640B2 (en) 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US6887270B2 (en) 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US7993390B2 (en) 2002-02-08 2011-08-09 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US7049322B2 (en) 2002-02-21 2006-05-23 Supergen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
US7261734B2 (en) 2002-04-23 2007-08-28 Boston Scientific Scimed, Inc. Resorption-controllable medical implants
US7008979B2 (en) 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US20040208908A1 (en) 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347660A1 (en) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln Thermoplastics containing antiphlogistics
US5279594A (en) * 1990-05-23 1994-01-18 Jackson Richard R Intubation devices with local anesthetic effect for medical use
US5512055A (en) * 1991-02-27 1996-04-30 Leonard Bloom Anti-infective and anti-inflammatory releasing systems for medical devices
EP0970711A2 (en) * 1998-06-30 2000-01-12 Ethicon, Inc. Process for coating stents
WO2001003607A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Aneurysm closure device assembly

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852163B2 (en) 2002-04-08 2014-10-07 Medtronic Ardian Luxembourg S.A.R.L. Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
US9192715B2 (en) 2002-04-08 2015-11-24 Medtronic Ardian Luxembourg S.A.R.L. Methods for renal nerve blocking
US9265558B2 (en) 2002-04-08 2016-02-23 Medtronic Ardian Luxembourg S.A.R.L. Methods for bilateral renal neuromodulation

Also Published As

Publication number Publication date
WO2004011055A2 (en) 2004-02-05
EP1526880A2 (en) 2005-05-04
US20120150096A1 (en) 2012-06-14
CA2506963A1 (en) 2004-02-05
JP2006514557A (en) 2006-05-11
JP4918222B2 (en) 2012-04-18
AU2003268048A1 (en) 2004-02-16
US20030224033A1 (en) 2003-12-04
EP1526880B1 (en) 2012-01-18
US8691264B2 (en) 2014-04-08
US8133501B2 (en) 2012-03-13

Similar Documents

Publication Publication Date Title
WO2004011055A3 (en) Implantable or insertable medical devices for controlled drug delivery
WO2005011769A3 (en) Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
WO2005044178A3 (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
CA2404459A1 (en) Surgical sling delivery system
MXPA05005315A (en) Medical devices incorporating deuterated rapamycin for controlled delivery thereof.
GB2338414A (en) Intravesical drug delivery system
EP1143935A3 (en) Controlled-release biocompatible ocular drug delivery implant devices and methods
EP2407203A3 (en) Solid therapeutic agent for use in an implantable drug delivery device
WO2000053253A3 (en) Implantable device for access to a treatment site
WO2004034879A3 (en) Screening techniques for management of a nervous system disorder
WO2004091444A3 (en) Implantable medical device comprising therapeutic agents with different diffusion rates
EP2258362A3 (en) Titration dosing regimen for controlled release tramadol
AU2003286568A1 (en) Drug infusion system with multiple medications
WO2005013936A3 (en) Manufacture of long term drug delivery devices with polyurethane based polymers
PL350583A1 (en) Combinations of formoterol and a tiotropium salt
WO2007098479A3 (en) Localized insulin delivery for bone healing
WO2006022996A3 (en) Dosage form containing multiple drugs
WO2003051452A8 (en) Drug implant injection device
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
WO2004037207A3 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
WO2003002170A3 (en) Minimally invasive drug delivery catheter
WO2004037199A3 (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
WO2005014103A3 (en) Stereotactic upper body fixation and positioning device
GB0201367D0 (en) Composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004524281

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2506963

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003748999

Country of ref document: EP

Ref document number: 2003268048

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2003748999

Country of ref document: EP